Encore Presentation: Exciting Genetic Discoveries Lead to Life-Changing CMT Therapies with Dr. Stephan Züchner Artwork

CMT 4 Me

CMT 4 Me is an emotional, heartfelt, and humorous podcast for the 3+ million people who have CMT (Charcot-Marie-Tooth disease), their friends, family, and the general public. CMT 4 Me provides a platform for people with CMT to have a voice, describe challenges, find ways to overcome those challenges, and share successes. Another goal is to spread CMT awareness and unite as a community. We will also cover research updates, fundraising, unique stories, interviews with the CMTA community, including board members, branch leaders, and CMTA team members. Have a story you’d like to share? Write to info@cmtausa.org. You may be our next guest on the new CMT 4 ME podcast! For more information on the CMTA, please visit our website: cmtausa.org

All Episodes

CMT 4 Me

Encore Presentation: Exciting Genetic Discoveries Lead to Life-Changing CMT Therapies with Dr. Stephan Züchner

March 25, 2024 • Chris and Elizabeth Ouellette • Season 1 • Episode 34

In this special replay, we revisit the riveting conversation with Dr. Stephan Züchner, a beacon of hope in the realm of genetic research for Charcot-Marie-Tooth (CMT) disease. As the chair of the Department of Human Genetics at the University of Miami Miller School of Medicine, Dr. Züchner has been at the forefront of groundbreaking discoveries that have the potential to transform the lives of those affected by CMT.

This episode sheds light on Dr. Züchner's journey from the vibrant streets of Berlin to the cutting-edge labs of Duke University and beyond. His relentless pursuit of understanding the genetic underpinnings of CMT has led to the identification of critical mutations, opening new avenues for targeted therapies.

Dive into an engaging discussion that spans the discovery of the SORD gene mutation, offering a glimmer of hope for a significant subset of CMT patients, to the innovative approaches in gene therapy that are on the horizon. Dr. Züchner's work not only illuminates the complex genetic landscape of CMT but also underscores the power of collaboration and data sharing in the scientific community.

As we re-examine this enlightening dialogue, join us in celebrating the strides made in genetic research and the ongoing quest to unravel the mysteries of CMT. For those who wish to support this vital research and the broader CMT community, please consider visiting CMTA USA.

For more information about CMT and to support the CMTA, please visit www.cmtausa.org